Private Wealth Partners’s Standard BioTools LAB Stock Holding History

Private Wealth Partners’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,630	Closed	-$742K	–	147
2015 Q1	$742K	Hold	17,630	–	–	0.17%	98
2014 Q4	$595K	Buy	+17,630	New	+$499K	0.14%	107

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Private Wealth Partners's LAB Position: Q2 2015 in Review

Private Wealth Partners sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 17,630 shares — an estimated $742K sold.

Private Wealth Partners first reported a position in LAB in Q4 2014 and held it in 2 quarters. The position peaked at $742K in Q1 2015. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

Private Wealth Partners reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
Private Wealth Partners sold 17,630 Standard BioTools shares in Q2 2015, an estimated $742K.
Private Wealth Partners first reported a position in Standard BioTools in Q4 2014 and held it in 2 quarters.
Private Wealth Partners's Standard BioTools position peaked at $742K in Q1 2015.
107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on Private Wealth Partners's 13F filing for Q2 2015, filed 23 Jul 2015.